GeoBusinessIQGeoBusinessIQ

LIMS: tracking a sample from login to a result somebody will sign

What this answers

Can we show who tested what, against which version of the specification, using which calibrated instrument?

A works laboratory holds up production. Batches wait for release, incoming material waits for approval, and a mislaid sample becomes a stopped line. A laboratory information management system exists to make that queue visible and the results defensible: every sample registered with its origin, every test assigned and timed, every result judged against a specification whose version is recorded, and every signature attributable to a person. In regulated production it is also the thing an inspector reads.

Written for: laboratory managers in manufacturing, quality control chemists and technicians, regulatory affairs staff in food, pharmaceutical and chemical plants.

Login is where traceability is won or lost

A sample that arrives labelled with a handwritten batch code and no sampling point has already lost most of its evidential value. Registration should capture where the material came from, who took it, when, under what conditions and against which order or vessel, and it should generate the identifier that follows the sample through the laboratory. Barcoding at the sampling point rather than at the bench removes the transcription step that causes most mix-ups. Where samples are taken by production staff rather than laboratory staff, the registration process has to be simple enough to survive being done in a noisy plant by someone wearing gloves.

A result means nothing without the specification it was judged against

Limits change: a customer tightens a requirement, a formulation is revised, a grade is introduced for a particular market. If the system evaluates results against whatever the current specification says, historical passes become unexplainable when the limits move. Specifications need to be versioned objects with effective periods, and each result must record the version applied at the time. This also handles the common situation where the same material is sold to several customers with different acceptance criteria, so a batch can be simultaneously acceptable for one and not for another without anyone maintaining parallel spreadsheets.

Instrument interfacing removes the error you cannot detect

Transcription mistakes are rare per reading and inevitable across a year of testing, and the ones that matter are those that turn a failing result into a passing one. Direct capture from balances, chromatography systems, spectrometers and titrators removes the keystroke and brings the instrument identity and run conditions with it. The work involved is usually underestimated because each instrument type behaves differently and older equipment may have no usable output at all. A staged approach that starts with the highest-volume tests and the instruments whose results carry the most weight delivers most of the benefit early.

Out-of-specification handling is a workflow, not a flag

When a result falls outside limits, what follows is a defined sequence: check for an assignable laboratory error, decide whether retesting is justified and on what basis, escalate to a named decision-maker, and record the disposition of the material. Systems that merely mark the result red leave that sequence to memory and to whoever is on duty. Configuring it properly prevents the two failure modes inspectors look for hardest — repeated testing until an acceptable result appears, and quiet invalidation of a result without a documented laboratory cause. Both are process failures that the software can make visible or can help conceal.

Regulated laboratories are judged on the record, not the result

Where medicines, medical devices or food safety are involved, the expectation is that data is attributable, legible, contemporaneous, original and accurate, and that the system can demonstrate it. That drives requirements which look bureaucratic from the outside: individual accounts rather than shared logins, audit trails that capture reasons for change, review of the trail as a routine activity, controlled instrument software, and validated configuration that is retested after upgrades. Planning for these from the start costs far less than discovering during an inspection that the audit trail was switched off to improve performance.

Frequently asked questions

Can quality control testing be handled inside the production system instead?
Simple pass or fail inspection recorded against a batch can be, and many plants do exactly that for basic checks. A laboratory with sample queues, multi-stage testing, instrument runs, retest rules, stability programmes and analyst qualification needs more structure than a production module typically offers. The decision point is usually the arrival of an external expectation: an accreditation scheme, a customer audit, or a regulator who wants to see how a result was produced rather than only what it was.
How do calibration records fit with laboratory results?
Every result should be attributable to an instrument whose calibration status at the time of the test is known. If an instrument is later found out of tolerance, you need to identify the results it produced since it was last confirmed good, which means the link has to be recorded at the time rather than reconstructed. Some laboratories manage this inside the laboratory system, others integrate with a separate instrument register; either works, provided the reverse lookup is possible without manual searching.
What usually goes wrong in these implementations?
Attempting to configure the system around every existing local practice, including the ones that exist because of an old constraint nobody remembers. The result is a fragile configuration that no upgrade survives. The second common problem is validating the initial setup thoroughly and then treating later configuration changes as routine, so the qualified state quietly lapses. Deciding early which practices are genuinely required, and controlling change afterwards, avoids most of the pain.

Data limitations

  • Manufacturing figures are operator-supplied inputs, not market data. GeoBusinessIQ holds no factory costs, production volumes, yields, cycle times, tooling prices or capacity data and does not estimate them — every result reflects only the figures you enter.

Explore the graph

Sources

  • United States Food and Drug Administration FDA (accessed )
    Covers: United States regulation of medical devices, pharmaceuticals, food and cosmetics, including manufacturing practice requirements.
    Does not cover: Product approvals for your product, inspection outcomes, or requirements outside United States jurisdiction.
    Why it matters: Cited only for the regulated sectors it actually governs, where manufacturing practice is set by the regulator.
    Review cadence: annual
  • European Medicines Agency EMA (accessed )
    Covers: European Union evaluation and supervision of medicines, including manufacturing and distribution practice.
    Does not cover: Marketing authorisation for a specific product, or inspection findings.
    Why it matters: Cited on pharmaceutical manufacturing pages as the European authority for the applicable practice framework.
    Review cadence: annual
  • International Laboratory Accreditation Cooperation ILAC (accessed )
    Covers: The international arrangement for recognition of testing, calibration and inspection laboratory accreditation.
    Does not cover: Individual laboratory scopes, calibration certificates, or measurement results.
    Why it matters: Cited on calibration and measurement pages to explain what accredited calibration means.
    Review cadence: annual

Educational and operational information only — not legal, engineering, safety, customs, tax, or financial advice. Requirements vary by jurisdiction, product, process, and contract; confirm with the relevant authority or a qualified professional before acting.

Last updated: